Trisk Bio

Trisk Bio is a biotech company in London, United Kingdom, founded in 2020. It has raised $16.6M across 2 rounds, most recently a $2.0M Seed in December 2021.

Custom AAV Manufacturing

Headquarters
London
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$16.6M
Last Round
$2.0M SeedDec 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Trisk Bio is a London-based contract manufacturer specializing in custom AAV (adeno-associated virus) production for gene therapy developers, offering fully scalable preclinical manufacturing processes from 1e13 vg research-grade batches up to 5e13–1e15 vg for non-human-primate-grade studies. The company develops bespoke, forecastable production processes across all capsid serotypes and transgenes, including high-throughput process optimization and analytical development, to make preclinical AAV manufacturing faster and more affordable. Trisk Bio has partnered with organizations including Dyno Therapeutics and NanoMosaic to expand its capsid engineering and AAV analytics capabilities.

Summary

It lists 1–10 employees. It has raised $16.6M in total across 2 rounds, most recently a $2.0M Seed round in Dec 2021. Investors include Matrix Partners and Quiet Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundDec 2021
$2.0M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trisk Bio on Indexed.vc
<a href="https://indexed.vc/companies/trisk-bio"><img src="https://indexed.vc/api/badge/company/trisk-bio" alt="Trisk Bio on Indexed.vc" width="260" height="76" /></a>